A centre that provides support for people in Devon with long-term health conditions including multiple sclerosis (MS) and ...
REGULAR health tests became mainstream during Covid and, ever since, the number of check kits has ballooned. Some are not reliable and a visit to your GP is a must if you have serious concerns.
Cape Town is at the forefront of wellness, with a handful of exceptional retreats a short drive from the city, where mindfulness and wellbeing take centre stage. From yoga workshops and nourishing ...
JACKSONVILLE, Fla. – Prostate cancer is the most common cancer in men in the U.S. after skin cancer, but it is often slow-growing and highly treatable. Now there is a minimally invasive treatment, ...
At 77 years old, Tyson Johnson has been in treatment for metastatic prostate cancer for more than 20 years. “I’m the healthiest dead man you’ve ever seen,” the Carthage resident said jokingly as he ...
Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that returned after radiotherapy. Matched analyses estimated 10-year ...
(WISH) — The American Cancer Society reports that about one in eight men will be diagnosed with prostate cancer in their lifetime. The average age of men who get diagnosed is 67. Today, less than 1% ...
AMPLITUDE is the first clinical trial to evaluate potential therapies for patients with mHSPC and known HRR gene alterations, with positive results supporting the niraparib-based combination regimen ...
A surgeon at St. Clair Hospital in Mt. Lebanon recently performed the first HIFU procedure for prostate cancer at St. Clair using advanced new ultrasound technology. This makes St. Clair the first ...
Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment. A recent ...
Wolinsky is a Chicago-based medical journalist and publisher of The Active Surveillor, a Substack newsletter that covers lower-risk prostate cancer and active surveillance. In 2002, at age 55, I ...
Enolen's fast track designation by the FDA aims to expedite its development for localized prostate cancer treatment, addressing unmet medical needs. The localized delivery technology targets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results